Abstract
Liver diseases affect hundreds of millions of people worldwide; most often the hepatocytes or cholangiocytes are damaged. Diseases of the biliary tract cause severe patient burden, and cholangiocytes, the cells lining the biliary tract, are sensitive to numerous drugs. Therefore, investigations into proper cholangiocyte functions are of utmost importance, which is restricted, in vitro, by the lack of primary human cholangiocytes allowing such screening. To investigate biliary function, including transepithelial transport, cholangiocytes must be cultured as three-dimensional (3D) ductular structures. We previously established murine intrahepatic cholangiocyte organoid-derived cholangiocyte-like cells (CLCs) and cultured them onto polyethersulfone hollow fiber membranes (HFMs) to generate 3D duct structures that resemble native bile ducts at the structural and functional level. Here, we established an efficient, stepwise method for directed differentiation of human intrahepatic cholangiocyte organoids (ICOs) into CLCs. Human ICO-derived CLCs showed key characteristics of cholangiocytes, such as the expression of structural and functional markers, formation of primary cilia, and P-glycoprotein-mediated transport in a polarized fashion. The organoid cultures exhibit farnesoid X receptor (FXR)-dependent functions that are vital to liver bile acid homeostasis in vivo. Furthermore, human ICO-derived CLCs cultured on HFMs in a differentiation medium form tubular architecture with some tight, confluent, and polarized monolayers that better mimic native bile duct characteristics than differentiated cultures in standard 2D or Matrigel-based 3D culture plates. Together, our optimized differentiation protocol to obtain CLC organoids, when applied on HFMs to form bioengineered bile ducts, will facilitate studying cholangiopathies and allow developing therapeutic strategies.
| Original language | English |
|---|---|
| Article number | 868857 |
| Pages (from-to) | 1-10 |
| Journal | Frontiers in Bioengineering and Biotechnology |
| Volume | 10 |
| DOIs | |
| Publication status | Published - 24 Jun 2022 |
Bibliographical note
Funding Information:This work was supported by the China Scholarship Council (No. 201808620130), and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant agreement no. 813839 (JF). Furthermore, this work was co-funded by the PPP Allowance made available by Health ∼ Holland, Top Sector Life Sciences & Health, Netherlands (No. LSHM20045-HSGF), to stimulate public–private partnerships.
Publisher Copyright:
Copyright © 2022 Wang, Faria, van der Laan, Penning, Masereeuw and Spee.
Funding
This work was supported by the China Scholarship Council (No. 201808620130), and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant agreement no. 813839 (JF). Furthermore, this work was co-funded by the PPP Allowance made available by Health ∼ Holland, Top Sector Life Sciences & Health, Netherlands (No. LSHM20045-HSGF), to stimulate public–private partnerships.
Keywords
- bioengineered bile duct
- cholangiocytes
- hollow fiber membrane
- intrahepatic cholangiocyte organoids
- monolayer
- perfusable
- polarity